Organization Profile

You just read:

MAQUET Cardiovascular Announces Results Of The IABP-SHOCK II Trial Of Intra-aortic Balloon Counterpulsation Therapy In Cardiogenic Shock Patients

News provided by

MAQUET Cardiovascular LLC

Aug 27, 2012, 02:06 ET